Tci Wealth Advisors, Inc. Eagle Pharmaceuticals, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$24.98 - $39.77 $449 - $715	-18 Reduced 13.14%	119 $3,000
Q3 2022 Nov 08, 2022	BUY	$26.42 - $47.12 $1,030 - $1,837	39 Added 39.8%	137 $4,000
Q2 2022 Jul 19, 2022	BUY	$41.26 - $51.35 $4,043 - $5,032	98 New	98 $4,000
Q4 2018 Jan 17, 2019	SELL	$36.72 - $67.73 $514 - $948	-14 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	14	14 $1,000

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.